Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 119

Similar articles for PubMed (Select 25088400)

1.

Inflammation-based scores do not predict post-transplant recurrence of hepatocellular carcinoma in patients within Milan criteria.

Parisi I, Tsochatzis E, Wijewantha H, Rodríguez-Perálvarez M, De Luca L, Manousou P, Fatourou E, Pieri G, Papastergiou V, Davies N, Yu D, Luong T, Dhillon AP, Thorburn D, Patch D, O'Beirne J, Meyer T, Burroughs AK.

Liver Transpl. 2014 Nov;20(11):1327-35. doi: 10.1002/lt.23969.

2.

Transarterial embolization as neo-adjuvant therapy pretransplantation in patients with hepatocellular carcinoma.

Tsochatzis E, Garcovich M, Marelli L, Papastergiou V, Fatourou E, Rodriguez-Peralvarez ML, Germani G, Davies N, Yu D, Luong TV, Dhillon AP, Thorburn D, Patch D, O'Beirne J, Meyer T, Burroughs AK.

Liver Int. 2013 Jul;33(6):944-9. doi: 10.1111/liv.12144. Epub 2013 Mar 26.

PMID:
23530918
3.

Postoperative neutrophil-to-lymphocyte ratio plus platelet-to-lymphocyte ratio predicts the outcomes of hepatocellular carcinoma.

Li C, Wen TF, Yan LN, Li B, Wang WT, Yang JY, Xu MQ.

J Surg Res. 2015 Sep;198(1):73-9. doi: 10.1016/j.jss.2015.05.003. Epub 2015 May 7.

PMID:
26022997
4.

Predictive value of pre-transplant platelet to lymphocyte ratio for hepatocellular carcinoma recurrence after liver transplantation.

Xia W, Ke Q, Wang Y, Wang W, Zhang M, Shen Y, Wu J, Xu X, Zheng S.

World J Surg Oncol. 2015 Feb 18;13:60. doi: 10.1186/s12957-015-0472-2.

5.

Neutrophil and platelet-to-lymphocyte ratio as new predictors of dropout and recurrence after liver transplantation for hepatocellular cancer.

Lai Q, Castro Santa E, Rico Juri JM, Pinheiro RS, Lerut J.

Transpl Int. 2014 Jan;27(1):32-41. doi: 10.1111/tri.12191. Epub 2013 Sep 30.

PMID:
24118272
6.

Impact of pre-operative transarterial embolization on the treatment of hepatocellular carcinoma with liver transplantation.

Cheng YF, Huang TL, Chen TY, Chen YS, Wang CC, Hsu SL, Tsang LL, Sun PL, Chiu KW, Jawan B, Eng HL, Chen CL.

World J Gastroenterol. 2005 Mar 14;11(10):1433-8.

7.

Extended postinterventional tumor necrosis-implication for outcome in liver transplant patients with advanced HCC.

Kornberg A, Witt U, Matevossian E, Küpper B, Assfalg V, Drzezga A, Hüser N, Wildgruber M, Friess H.

PLoS One. 2013;8(1):e53960. doi: 10.1371/journal.pone.0053960. Epub 2013 Jan 22.

8.

A scoring model based on neutrophil to lymphocyte ratio predicts recurrence of HBV-associated hepatocellular carcinoma after liver transplantation.

Wang GY, Yang Y, Li H, Zhang J, Jiang N, Li MR, Zhu HB, Zhang Q, Chen GH.

PLoS One. 2011;6(9):e25295. doi: 10.1371/journal.pone.0025295. Epub 2011 Sep 26.

9.

Milan criteria are useful predictors for favorable outcomes in hepatocellular carcinoma patients undergoing liver transplantation after transarterial chemoembolization.

Kim do Y, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC, Shin SW, Choo SW, Do YS, Rhee JC.

World J Gastroenterol. 2006 Nov 21;12(43):6992-7.

10.

Impact of transarterial therapy in hepatitis C-related hepatocellular carcinoma on long-term outcomes after liver transplantation.

Cabrera R, Dhanasekaran R, Caridi J, Clark V, Morelli G, Soldevila-Pico C, Magglioca J, Nelson D, Firpi RJ.

Am J Clin Oncol. 2012 Aug;35(4):345-50. doi: 10.1097/COC.0b013e31821631f6.

11.

Histological differentiation predicts post-liver transplantation survival time.

Li WX, Li Z, Gao PJ, Gao J, Zhu JY.

Clin Res Hepatol Gastroenterol. 2014 Apr;38(2):201-8. doi: 10.1016/j.clinre.2013.11.002. Epub 2013 Dec 30.

PMID:
24388339
12.

How to decide about liver transplantation in patients with hepatocellular carcinoma: size and number of lesions or response to TACE?

Otto G, Schuchmann M, Hoppe-Lotichius M, Heise M, Weinmann A, Hansen T, Pitton MP.

J Hepatol. 2013 Aug;59(2):279-84. doi: 10.1016/j.jhep.2013.04.006. Epub 2013 Apr 12.

PMID:
23587474
13.

Recurrent hepatocellular carcinoma after transplantation: use of a pathological score on explanted livers to predict recurrence.

Parfitt JR, Marotta P, Alghamdi M, Wall W, Khakhar A, Suskin NG, Quan D, McAllister V, Ghent C, Levstik M, McLean C, Chakrabarti S, Garcia B, Driman DK.

Liver Transpl. 2007 Apr;13(4):543-51.

14.

Radiologic-histological correlation of hepatocellular carcinoma treated via pre-liver transplant locoregional therapies.

El-Gazzaz G, Sourianarayanane A, Menon KV, Sanabria J, Hashimoto K, Quintini C, Kelly D, Eghtesad B, Miller C, Fung J, Aucejo F.

Hepatobiliary Pancreat Dis Int. 2013 Feb;12(1):34-41.

15.

Neutrophil-lymphocyte ratio predicts the prognosis of patients with hepatocellular carcinoma after liver transplantation.

Xiao GQ, Liu C, Liu DL, Yang JY, Yan LN.

World J Gastroenterol. 2013 Dec 7;19(45):8398-407. doi: 10.3748/wjg.v19.i45.8398.

16.

Rate of tumor growth predicts recurrence of hepatocellular carcinoma after liver transplantation in patients beyond Milan or UCSF criteria.

Hanouneh IA, Macaron C, Lopez R, Aucejo F, Zein NN.

Transplant Proc. 2011 Dec;43(10):3813-8. doi: 10.1016/j.transproceed.2011.09.043.

PMID:
22172852
17.

Neutrophil-lymphocyte ratio predicts overall and recurrence-free survival after liver transplantation for hepatocellular carcinoma.

Limaye AR, Clark V, Soldevila-Pico C, Morelli G, Suman A, Firpi R, Nelson DR, Cabrera R.

Hepatol Res. 2013 Jul;43(7):757-64. doi: 10.1111/hepr.12019. Epub 2012 Nov 30.

18.

Postinterventional tumor necrosis predicts recurrence-free long-term survival in liver transplant patients with advanced hepatocellular carcinoma.

Kornberg A, Witt U, Küpper B, Wildgruber M, Friess H.

Transplant Proc. 2013 Jun;45(5):1913-5. doi: 10.1016/j.transproceed.2013.01.004.

PMID:
23769071
19.

Doxorubicin-eluting bead vs conventional transcatheter arterial chemoembolization for hepatocellular carcinoma before liver transplantation.

Nicolini D, Svegliati-Baroni G, Candelari R, Mincarelli C, Mandolesi A, Bearzi I, Mocchegiani F, Vecchi A, Montalti R, Benedetti A, Risaliti A, Vivarelli M.

World J Gastroenterol. 2013 Sep 14;19(34):5622-32. doi: 10.3748/wjg.v19.i34.5622.

20.

Prognostic factors affecting survival at recurrence of hepatocellular carcinoma after living-donor liver transplantation: with special reference to neutrophil/lymphocyte ratio.

Harimoto N, Shirabe K, Nakagawara H, Toshima T, Yamashita Y, Ikegami T, Yoshizumi T, Soejima Y, Ikeda T, Maehara Y.

Transplantation. 2013 Dec 15;96(11):1008-12. doi: 10.1097/TP.0b013e3182a53f2b.

PMID:
24113512
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk